EUVIMEDEUVIMED entdecken
Crossref

BDNF Loaded Amino Acid‐Catecholamine Hybrid Nanoparticles as Curative Agents Against Cognitive Decline in Alzheimer's Disease

Himanshu Sekhar Panda iD, Mrunali D Dhokne, Sumit Thakur, Nisha Singh, Ashok Kumar Datusalia, Jiban Jyoti Panda iD

Small · 2025

DOI: 10.1002/smll.202411701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Himanshu Sekhar Panda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Supramolecular Nanotherapeutics Laboratory, Chemical Biology Unit, Institute of Nano Science and Technology, Sector-81, Knowledge City, Sah…. Hauptthemen laut MEDLINE: Alzheimer Disease, Nanoparticles, Cognitive Dysfunction, Brain-Derived Neurotrophic Factor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: SERB-POWER, Har Gobind Khorana-Innovative Young Biotechnologist Award, DBT grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is marked by the buildup of neurotoxic Aβ plaques.In this study, EGCG‐dopamine‐tryptophan nanoparticles (EDTNPs) that prevent Aβ fibrillization, aid plaque clearance, improve oxidative balance, reduce neuronal damage, and enhance cell survival through protective effects are synthesized. To boost neuroprotection further, BDNF, a neurotrophic factor that promotes neuronal growth, are loaded onto the EDTNPs (B‐EDTNPs), leading to a notable increase in the protection of neuronal cells. B‐EDTNPs exhibit a pronounced neuroprotective effect against FF and Aβ (1‐42) fibril‐induced toxicity in SH‐SY5Y neuroblastoma cells, enhancing cell viability from ≈ 37% to 92% and from 48% to 88%, respectively; which is ≈20% and ≈21% higher compared to EDTNPs at 24 h duration. Studies involving animal models further demonstrate that B‐EDTNPs effectively dislodge amyloid aggregates in vivo, leading to a significant reduction in plaque accumulation ( p < 0.001). This intervention not only promotes the clearance of toxic aggregates but also noticeably suppresses the NF‐κB and TNF‐α inflammatory biomarkers, aiding in restoring cognitive function and enhancing behavioral outcomes in treated BALB/c AD animal models. The theoretical studies show that NP components interact with Aβ (1–42) polypeptides, promoting disaggregation. This highlights a novel approach for creating effective nanocomposites that combine Aβ inhibitors with antioxidants to target AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNanoparticlesCognitive DysfunctionBrain-Derived Neurotrophic FactorAmino AcidsAnimalsHumansAmyloid beta-PeptidesCell Line, TumorCell SurvivalNeuroprotective AgentsMicePeptide FragmentsMaleCatechin

Stichwörter der Autor:innen

BDNF, catecholaminesalzheimer's diseaseanti‐inflammationnanotheranosticsneuroprotectionprotein delivery

Substanzen

Brain-Derived Neurotrophic FactorAmyloid beta-PeptidesAmino AcidsNeuroprotective AgentsPeptide FragmentsCatechin

Autor:innen und Institutionen

  • Brain and Supramolecular Nanotherapeutics Laboratory, Chemical Biology Unit, Institute of Nano Science and Technology, Sector-81, Knowledge City, Sahibzada Ajit Singh Nagar, Punjab, 140306, India.
  • Laboratory of Molecular NeuroTherapeutics, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, Uttar Pradesh, 226002, India.
  • Gujarat Biotechnology University, Gandhinagar, Gujarat, 382355, India.

ORCID-Profile: Himanshu Sekhar Panda, Jiban Jyoti Panda

Förderung

  • SERB-POWER
  • Har Gobind Khorana-Innovative Young Biotechnologist Award
  • DBT grant
  • CSIR extramural grant
  • ICMR extramural grant

Zitieren

APA

Panda, H. S., Dhokne, M. D., Thakur, S., Singh, N., Datusalia, A. K., & Panda, J. J. (2025). BDNF Loaded Amino Acid‐Catecholamine Hybrid Nanoparticles as Curative Agents Against Cognitive Decline in Alzheimer's Disease. Small. https://doi.org/10.1002/smll.202411701

Vancouver

Panda HS, Dhokne MD, Thakur S, Singh N, Datusalia AK, Panda JJ. BDNF Loaded Amino Acid‐Catecholamine Hybrid Nanoparticles as Curative Agents Against Cognitive Decline in Alzheimer's Disease. Small. 2025. doi:10.1002/smll.202411701

BibTeX
@article{Panda2025,
  author = {Panda, Himanshu Sekhar and Dhokne, Mrunali D and Thakur, Sumit and Singh, Nisha and Datusalia, Ashok Kumar and Panda, Jiban Jyoti},
  title = {BDNF Loaded Amino Acid‐Catecholamine Hybrid Nanoparticles as Curative Agents Against Cognitive Decline in Alzheimer's Disease},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202411701}
}
Kostenlos starten →